Saint Elizabeth Healthcare

Edgewood, Kentucky 41017-3403

2 studies enrolling now · 9 studies all time

What they study most

Arrhythmia, Bradycardia, Coronary Artery Disease, Fecal Incontinence, Heart Failure, Heart Failure NYHA Class II, Heart Failure NYHA Class III, Non-obstructive Urinary Retention, Non-small Cell Lung Cancer, Overactive Bladder, Pancreas Adenocarcinoma, Tachyarrhythmia

Studies at this site

• Prevail Global Study — Recruiting now
• Lead Evaluation for Defibrillation and Reliability Post Approval Study — Enrolling by invitation
• Personalized Therapy Study - Attain Stability Quad Post-Approval Study — Running, not enrolling
• Micra AV Transcatheter Pacing System Post-Approval Registry — Completed
• Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3) — Completed
• Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure — Completed
• EF-36/Keynote B36: A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer — Stopped early
• InterStim Micro Post Market Clinical Follow-up Study (ELITE) — Stopped early
• Medtronic Reveal LINQ™ In-Office 2 (RIO 2) Study United States — Completed